Telgio Adverse Reactions

Infections and infestations: Urinary tract infections (including cystitis), upper respiratory tract infections, sepsis include fatal outcome.
Blood and lymphatic system disorders: Anemia, eosinophilia, thrombocytopenia.
Immune system disorders: Anaphylactic reaction, hypersensitivity.
Metabolism and nutrition disorders: Hyperkalemia, hypoglycemia (in diabetic patients).
Psychiatric disorders: Anxiety, insomnia, depression.
Nervous system disorders: Syncope (faint).
Eye disorders: Visual disturbance.
Ear and labyrinth disorders: Vertigo.
Cardiac disorders: Bradycardia, tachycardia.
Vascular disorders: Hypotension, orthostatic hypotension.
Respiratory, thoracic, and mediastinal disorders: Dyspnea.
Gastrointestinal disorders: Abdominal pain, diarrhea, dry mouth, dyspepsia, flatulence, stomach discomfort, vomiting.
Hepatobiliary disorders: Hepatic function abnormal/liver disorder*.
*Most cases of hepatic function abnormal/liver disorder occurred in patients in Japan, who are more likely to experience these adverse drug reactions.
Skin and subcutaneous tissue disorders: Pruritus, hyperhidrosis, rash, angioedema (with fatal outcome), eczema, erythema, urticaria, drug eruption, toxic skin eruption.
Musculoskeletal, connective tissue, and bone disorders: Back pain, muscle spasms (cramps in leg), myalgia, arthralgia, pain in extremity (leg pain), tendon pain (tendinitis like symptoms).
Renal and urinary tract disorders: Renal impairment including acute renal failure (see Precautions).
General disorders and administration site conditions: Chest pain, influenza-like illness, asthenia (weakness).
Investigations: Blood creatinine increased, hemoglobin decreased, blood uric increased, hepatic enzymes increased, blood creatine phosphokinase (CPK) increased.